For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

7 Stocks To Buy With Potential Upside of Up To 51% From Sharekhan

|

Sharekhan's Value Report for the month of Sept 2021 has some interesting stocks to buy. We have pulled 7 stocks that have a "buy" call from its Value Report, which can yield returns of as high as 51.1% from the current market price of the stocks. We are not saying that all 7 can gain 51%, we are emphasizing that they are up to 51% as per the report.

 

7 stocks that you can buy according to Sharekhan’s Value Report

7 stocks that you can buy according to Sharekhan’s Value Report

Company Name Current market price, Sept 10 Target price (Sharekhan) Gains %
Zee Entertainment Rs 182 Rs 275 51.1%
Granules India Rs 328 Rs 475 44.82%
TCI Ltd Rs 427 Rs 541 26.87%
Va Tech Wabag Rs 335 Rs 435 29.85%
Sadhbhav Engineering Rs 51 Rs 68 33.33%
Power Grid Rs 173 Rs 217 25.43%
NTPC Rs 117 Rs 140 19.66%

Zee Entertainment has an upside potential
 

Zee Entertainment has an upside potential

According to the report, Zee Entertainment has the best potential from amongst these 7 stocks to generate returns. The stock has over the years taken a knock as the promoters pledged shares to pay of their debts became an issue.

However, the founder of the group Subhash Chandra said that nearly 91.25 of the total debt to lenders has been settled.

"I am happy to report that we have come out of the financial stress situation by settling 91.2% of our total debt to 43 lenders in 110 accounts. About 88.3% of the amount has been paid, while the remaining 2.9% is in the process of being paid. We are making all the required efforts to settle the remaining 8.8% of our total debt," Chandra said in an open letter.

Granules India, TCI Ltd are other stocks that can deliver

Granules India, TCI Ltd are other stocks that can deliver

According to Sharekhan's report the other stocks that can deliver is Granules India and TCI Ltd. Recently, Granules India received licence from Defence Research & Development Organisation to manufacture and market Covid-19 treatment drug, 2- Deoxy-D-Glucose (2-DG). Developed by DRDO, 2-DG has been granted permission b y the Drug Controller for emergency use as adjunct therapy in moderate to severe Covid-19 patients, Granules India has said. However, unlike most of the markets the stock has already run-up.

From time to time, while we do highlight reports of brokerages, we wish to point out that the markets are overvalued at the moment based on price to earnings for Sensex companies. According to broking firm Motilal Oswal, the Sensex is currently trading at 18% premium to long term averages, and hence prudence would be better. Staggered investing is the best bet when the markets are buoyant. Investors should exercise a degree of caution give the way the markets have rallied in the last 2-3 months. In fact, 1,000 points gain on the Nifty has come in just 19 trading sessions, which makes it time to be cautious.

Disclaimer

Disclaimer

The article is informational in nature, which is taken from the brokerage report of Sharekhan. Please do consult a professional advisor before you invest in equities. Greynium Information Technologies Pvt Ltd, its subsidiaries, associates and authors do not accept culpability for losses and/or damages arising based on information in the article.

Story first published: Saturday, September 11, 2021, 5:00 [IST]
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X